-
AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline
AbbVie (NYSE: ABBV) and Nimble Therapeutics today announced a definitive agreement under which AbbVie will acquire Nimble, including its lead...
December 13, 2024
-
Fluence Energy, Inc. Announces Closing of Offering of $400.0 Million of Convertible Senior Notes due 2030
Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a global market leader delivering intelligent energy storage, operational services, and...
December 13, 2024
By: Traders on Trend
-
Unisys President and Chief Operating Officer Mike Thomson to Discuss Recently Announced April 1, 2025, CEO Transition at the Needham Growth Conference
Unisys (NYSE: UIS) will participate in the Needham Growth Conference in New York City. Unisys President and Chief Operating Officer, Mike Thomson, will...
December 13, 2024
-
THE MEXICO FUND, INC. DECLARES DISTRIBUTION
The Mexico Fund, Inc. (NYSE: MXF), announced that the Board of Directors (Board) declared a distribution of $0.22 per share to stockholders...
December 13, 2024
-
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies...
December 12, 2024
-
Clarivate Launches AI-Powered Patent Search Solution in Derwent
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of AI Search in Derwent™. Combining...
December 12, 2024
-
Toll Brothers Announces Cash Dividend
Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, today announced that its Board of Directors has...
December 12, 2024
By: Traders on Trend
-
Scholastic Corporation Announces Third Quarter Dividend
Scholastic Corporation (NASDAQ: SCHL) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on the...
December 12, 2024
-
AbbVie Completes Acquisition of Aliada Therapeutics
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition,...
December 11, 2024
-
New Fortress Energy Executes 10 Year Charter for Energos Eskimo
New Fortress Energy Inc. (NASDAQ: NFE) (“NFE” or the “Company”) has executed a 10 year charter agreement for the Energos...
December 11, 2024